Biotech Startups
9,990 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
Canal Biosciences develops DNA library preparation technology for next-generation sequencing, centered on its TrueLink platform and DISTAL-seq products that attach sequencing adaptors to native DNA termini without end repair to preserve template integrity. Its methods target high-precision NGS applications such as liquid biopsy, methylation sequencing, and minimal residual disease detection in cancer.
0 investors
0 investors
0 investors
0 investors
CancerVax develops cancer therapeutics using lipid nanoparticle technology in partnership with Cytiva. The company is focused on creating nanoparticle-based treatments for cancer patients.
0 investors
0 investors
Cannabinoid API Solutions distributes pharmaceutical-grade hemp-derived cannabinoid active pharmaceutical ingredients to pharmaceutical companies conducting clinical and commercial activities. The company partners with 22nd Century Group and GVB Biopharma, which manufacture isolate-form APIs including CBD, CBG, CBN, and other minor cannabinoids.
0 investors
0 investors
Cantex Pharmaceuticals is a pharmaceutical company. The website is currently under construction, so no details about its products or focus are available.
0 investors
0 investors
Capio Biosciences develops the CapioCyte platform, an ultra-sensitive technology for capturing and analyzing circulating tumor cells (CTCs) from whole blood. The oncology diagnostics tool is aimed at cancer research and potential future clinical use to support treatment decisions.
0 investors
Capitol Pharmacy is a medical marijuana dispensary offering products such as flower, pre-rolls, extracts, vapes, and edibles to registered patients, with online ordering and pickup or delivery. It also helps patients obtain medical marijuana cards and connects them with physicians, operating in Louisiana.
0 investors
0 investors
0 investors
0 investors
Cardax is a consumer health company that markets ZanthoSyn, a physician-recommended astaxanthin dietary supplement aimed at inflammatory health. The company previously developed pharmaceuticals for inflammation-driven diseases and holds pre-clinical candidates for cardiovascular inflammation/dyslipidemia (CDX-101) and macular degeneration (CDX-301).
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors